SELECT FROM MENU

Therapy Areas
Drug Classes

       Therapy Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Advanced NSCLC

Advanced NSCLC

SCLC

SCLC

Biomarkers

Biomarkers

       Drug Classes

Targeted Therapies

Targeted Therapies

Immunotherapies

Immunotherapies

ADCs

ADCs

Hossein Borghaei

Hossein Borghaei

Fox Chase Cancer Center, Philadelphia

Dr. Hossein Borghaei is Chief of the Division of Thoracic Medical Oncology and the Gloria and Edmund M. Dunn Chair in Thoracic Oncology at Fox Chase Cancer Center in Philadelphia, United States. His research centers on immunotherapy and antibody-based and targeted therapies for non-small cell lung cancer and malignant pleural mesothelioma. He was first author of the practice-changing CheckMate-057 nivolumab trial and an investigator on CheckMate-227, co-directs the Immune Monitoring Facility, and serves on scientific advisory and governance bodies for the American Lung Association and AACR. He is a frequent speaker at major international thoracic oncology congresses.

Connect

Hossein Borghaei

Featured in

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.